Genetic Clues for Skin Cancer Therapies Suffern NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

Timothy Corey
(201) 337-5100
180 Ramapo Valley Rd
Oakland, NJ
Linda Marcus
(201) 891-4373
271 Godwin Ave
Wyckoff, NJ
Jill Fetell
(914) 631-7911
13 Neperan Rd
Tarrytown, NY
Hyun S Ellen Kwark
(914) 285-7419
Westchester Med Ctr, 100 Grasslands Rd
Valhalla, NY
Joseph Di Pietro
(914) 779-6666
12 Studio Arc
Bronxville, NY
Jay Heldman
(201) 797-7770
23-00 State Rt 208
Fair Lawn, NJ
Jonathan Dosik
(201) 652-6060
348 S Maple Ave
Glen Rock, NJ
Philip Blank
(914) 747-5600
325 Manville Rd
Pleasantville, NY
Matthew Nat Harris
(914) 285-7000
Ny Med Col/Westchester Cnty
Valhalla, NY
Lester Klein
(914) 963-0010
984 North Broadway
Yonkers, NY
Data Provided by:
  

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Healing Facial Spider Veins Suffern NY
Aging, genetics, hormones, over exposure to the sun, smoking, skin care therapies and other lifestyle options can break down your skin and let's don't forget facial spider veins. But the good news is that there are treatment options available to improve the skin's appearance and to heal spider veins in face.
- Gene Mutation in Dogs Suffern NY
- Follow Up After Skin Cancer Suffern NY
- Getting a Botox Cosmetic Injection Suffern NY
- Filling in Wrinkles with Dermal Fillers Suffern NY
- Delayed Prostate Cancer Therapy Suffern NY
- High Levels of Selenium Decreases Incidence of Skin Cancer. Suffern NY
- Risk Factors for Squamous Cell Cancer of the Skin Suffern NY
- Breast Cancer Treatment Suffern NY
- Risks for Childhood Cancer Survivors Suffern NY